Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children

Clinical trial NCT05053594 · UNKNOWN

Trial details

NCT number: NCT05053594
Sponsor: Pontificia Universidade Catolica de Sao Paulo
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromuscular Blockade Neuromuscular Block, Residual Neuromuscular Block Prolonged

Start date: 2021-10-01
Primary completion: 2022-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.